Vedanta Ltd
NSE:VEDL
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
250.7
522
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Vedanta Ltd
Current Assets | 519.2B |
Cash & Short-Term Investments | 279.7B |
Receivables | 70.2B |
Other Current Assets | 169.4B |
Non-Current Assets | 1.4T |
Long-Term Investments | 36.6B |
PP&E | 1.2T |
Intangibles | 48.1B |
Other Non-Current Assets | 133.7B |
Current Liabilities | 786.6B |
Accounts Payable | 101B |
Other Current Liabilities | 685.7B |
Non-Current Liabilities | 814.2B |
Long-Term Debt | 511.7B |
Other Non-Current Liabilities | 302.6B |
Balance Sheet
Vedanta Ltd
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
10 982
|
22 004
|
98 637
|
25 730
|
72 290
|
50 600
|
48 540
|
86 710
|
69 260
|
28 120
|
|
Cash |
4 941
|
8 744
|
85 631
|
18 230
|
42 370
|
23 920
|
26 610
|
54 080
|
60 780
|
26 830
|
|
Cash Equivalents |
6 041
|
13 260
|
13 006
|
7 500
|
29 920
|
26 680
|
21 930
|
32 630
|
8 480
|
1 290
|
|
Short-Term Investments |
490 843
|
545 091
|
501 364
|
290 450
|
284 250
|
315 520
|
268 850
|
227 690
|
132 300
|
117 960
|
|
Total Receivables |
53 989
|
38 018
|
33 984
|
73 030
|
84 690
|
68 850
|
117 940
|
184 920
|
211 290
|
218 560
|
|
Accounts Receivables |
36 677
|
26 373
|
24 279
|
35 950
|
35 480
|
22 170
|
33 010
|
45 930
|
54 350
|
31 480
|
|
Other Receivables |
17 312
|
11 645
|
9 705
|
37 080
|
49 210
|
46 680
|
84 930
|
138 990
|
156 940
|
187 080
|
|
Inventory |
95 516
|
86 696
|
107 986
|
138 950
|
147 240
|
127 830
|
112 090
|
170 930
|
172 160
|
146 330
|
|
Other Current Assets |
34 706
|
36 625
|
25 990
|
22 980
|
9 810
|
12 400
|
14 640
|
13 130
|
20 060
|
8 270
|
|
Total Current Assets |
686 035
|
728 433
|
767 961
|
551 140
|
598 280
|
575 200
|
562 060
|
683 380
|
605 070
|
519 240
|
|
PP&E Net |
1 053 691
|
942 243
|
935 053
|
954 700
|
1 177 510
|
1 066 070
|
1 033 090
|
1 062 200
|
1 110 410
|
1 170 460
|
|
PP&E Gross |
1 053 691
|
942 243
|
935 053
|
954 700
|
1 177 510
|
1 066 070
|
1 033 090
|
1 062 200
|
1 110 410
|
1 170 460
|
|
Accumulated Depreciation |
559 502
|
724 011
|
769 956
|
840 540
|
1 176 710
|
1 482 060
|
1 471 490
|
1 579 230
|
1 754 700
|
1 850 660
|
|
Intangible Assets |
350 428
|
114 676
|
108 062
|
168 640
|
36 050
|
8 820
|
34 750
|
31 250
|
42 320
|
48 060
|
|
Note Receivable |
47 181
|
51 879
|
70 874
|
87 590
|
114 930
|
102 550
|
157 260
|
139 530
|
97 050
|
106 570
|
|
Long-Term Investments |
323
|
488
|
729
|
30 530
|
54 400
|
14 410
|
10 540
|
14 180
|
19 480
|
27 110
|
|
Other Long-Term Assets |
91 300
|
114 593
|
107 616
|
53 250
|
39 260
|
69 170
|
59 410
|
53 280
|
79 440
|
36 630
|
|
Total Assets |
2 228 957
N/A
|
1 952 311
-12%
|
1 990 296
+2%
|
1 845 850
-7%
|
2 020 430
+9%
|
1 836 220
-9%
|
1 857 110
+1%
|
1 983 820
+7%
|
1 953 770
-2%
|
1 908 070
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
148 292
|
161 624
|
184 591
|
178 430
|
173 520
|
169 720
|
76 240
|
103 800
|
110 430
|
100 950
|
|
Accrued Liabilities |
6 519
|
28 073
|
8 390
|
9 700
|
11 130
|
13 050
|
12 490
|
4 140
|
7 230
|
8 600
|
|
Short-Term Debt |
103 566
|
122 897
|
322 450
|
219 510
|
229 820
|
130 760
|
37 150
|
74 340
|
124 580
|
42 640
|
|
Current Portion of Long-Term Debt |
57 177
|
61 098
|
90 690
|
94 190
|
85 230
|
98 440
|
158 320
|
97 940
|
105 500
|
173 380
|
|
Other Current Liabilities |
108 615
|
169 710
|
220 632
|
170 640
|
266 710
|
221 250
|
307 180
|
374 730
|
522 730
|
461 040
|
|
Total Current Liabilities |
424 168
|
543 403
|
826 753
|
672 470
|
766 410
|
633 220
|
591 380
|
654 950
|
870 470
|
786 610
|
|
Long-Term Debt |
518 357
|
493 784
|
302 551
|
267 890
|
347 210
|
369 270
|
381 220
|
363 550
|
436 200
|
511 690
|
|
Deferred Income Tax |
157 498
|
32 508
|
20 837
|
42 180
|
44 840
|
28 850
|
22 150
|
44 350
|
59 220
|
101 520
|
|
Minority Interest |
467 765
|
365 611
|
139 279
|
159 610
|
152 270
|
171 120
|
151 380
|
173 210
|
100 040
|
113 470
|
|
Other Liabilities |
73 806
|
76 614
|
95 875
|
70 580
|
86 730
|
87 410
|
88 200
|
93 930
|
93 610
|
87 560
|
|
Total Liabilities |
1 641 594
N/A
|
1 511 919
-8%
|
1 385 295
-8%
|
1 212 730
-12%
|
1 397 460
+15%
|
1 289 870
-8%
|
1 234 330
-4%
|
1 329 990
+8%
|
1 559 540
+17%
|
1 600 850
+3%
|
|
Equity | |||||||||||
Common Stock |
2 965
|
2 965
|
3 718
|
3 720
|
3 720
|
3 720
|
3 720
|
3 720
|
3 720
|
3 720
|
|
Retained Earnings |
384 152
|
244 142
|
417 737
|
424 860
|
408 740
|
322 810
|
398 070
|
420 720
|
151 220
|
82 950
|
|
Additional Paid In Capital |
199 650
|
199 650
|
190 091
|
190 090
|
190 090
|
190 090
|
190 090
|
190 090
|
190 090
|
190 090
|
|
Other Equity |
597
|
6 365
|
6 545
|
14 450
|
20 420
|
29 730
|
30 900
|
39 300
|
49 200
|
30 460
|
|
Total Equity |
587 363
N/A
|
440 392
-25%
|
605 001
+37%
|
633 120
+5%
|
622 970
-2%
|
546 350
-12%
|
622 780
+14%
|
653 830
+5%
|
394 230
-40%
|
307 220
-22%
|
|
Total Liabilities & Equity |
2 228 957
N/A
|
1 952 311
-12%
|
1 990 296
+2%
|
1 845 850
-7%
|
2 020 430
+9%
|
1 836 220
-9%
|
1 857 110
+1%
|
1 983 820
+7%
|
1 953 770
-2%
|
1 908 070
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
2 965
|
2 965
|
2 965
|
3 711
|
3 705
|
3 706
|
3 708
|
3 711
|
3 716
|
3 712
|